Fleury buys Unilab for BRL 55 million as XP keeps Fleury stock Neutral

Published on 10/21/2026 at 06:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Unilab adds 11 diagnostic units and BRL 65 million in annual revenue. Fleury stock faces third-quarter results on November 5, 2026.

Unilab deal and earnings dates

Fleury agreed to buy Unilab for BRL 55.00 million on October 1, 2026.
Second-quarter revenue reached BRL 2.32 billion, up 14.44 percent year over year.
Third-quarter results are scheduled for November 5, 2026, with the conference call on November 6, 2026.

Fleury, BRFLRYACNOR5, Illustration mit AI erstellt.

Fleury (BRFLRYACNOR5) agreed to acquire Unilab for BRL 55.00 million on October 1, 2026, adding 11 diagnostic units and BRL 65.00 million in last-twelve-month revenue. XP Investimentos described the transaction as strategically positive while keeping a Neutral view on Fleury.

What does Unilab add?

The acquisition expands Fleury's presence in the interior of Sao Paulo and adds diagnostic services outside the group's existing core locations. Unilab generated BRL 65.00 million in revenue over the last twelve months and operated with a 20.00 percent margin, according to XP Investimentos.

Three milestones shape the story

On May 29, 2026, Fleury completed the acquisition of GIP Medicina Diagnostica, operator of Femme, for an enterprise value of BRL 207.50 million. In August 2026, the group raised BRL 1.825 billion through two debenture series, according to Gazeta Mercantil. The Unilab agreement followed on October 1, 2026, for BRL 55.00 million.

What will investors watch next?

Fleury's second-quarter revenue was BRL 2.32 billion, up 14.44 percent from the same period of 2025, while net income rose 45.70 percent to BRL 221.90 million. The figures show why the next report matters: the company is expanding, but valuation and integration remain central questions.

Two dates are scheduled

The investor-relations calendar sets the third-quarter 2026 earnings release for November 5, 2026, after the market, followed by the conference call on November 6, 2026. The call is scheduled for 9:00 a.m. ET, according to Fleury.

Stock valuation meets operating growth

Fleury stock was last at BRL 28.20 on October 20, 2026 at 9:31 p.m. BRT on B3. The 52-week range was BRL 13.90 to BRL 28.58, and market capitalization stood at BRL 15.3 billion as of October 21, 2026.